Abstract
One of the most important parameters to evaluate severity and type of cholestasis disease is gamma-glutamyl transferase and citrin protein measurements. The objective of this study was to assess the clinical value of serum citrin protein with gamma-glutamyl transferase in children with cholestasis. 60 subjects with diseases and 25 healthy subjects distributed intothree groups, citrinand gamma-glutamyl transferasewere measured for all case and control studies by enzyme linked immunosorbent Assay. The results showed serum citrin has a highly significantly decreased in an intra- and extrahepatic cholestasis groups when compared with control (P<0.001), serum gamma-glutamyl transferasehas a highly significantly elevated in an intrahepatic cholestasis group when compared with control (P<0.003). From these findings it was concluded that serum gamma-glutamyl transferase level is a good marker in determining the severity of cholestasis disease, serum citrin may be useful in future to diagnose the cholestasis caused by citrin deficiency.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Public Health Research & Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
